Skip to main content
RSNA Journals logoLink to RSNA Journals
. 2022 Aug 22;304(3):E57. doi: 10.1148/radiol.229015

Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram

Stacey Wolfson, Eric Kim, Anastasia Plaunova, Rita Bukhman, Ruth D Sarmiento, Naziya Samreen, Divya Awal, Monica M Sheth, Hildegard B Toth, Linda Moy, Beatriu Reig
PMCID: PMC9434806  PMID: 35994402

Originally published in:

https://doi.org/10.1148/radiol.213227

Erratum in:

https://doi.org/10.1148/radiol.229015

An error appeared in Figure 1: the graph in part A appeared twice; the graph in Figure 1A was changed to appear once. The y-axis has been relabeled to say Number of patients. The Figure 1 legend was revised as follows: (B) Graphs compare patients with LAD and follow-up imaging. Bars show the number of examinations assigned Breast Imaging Reporting and Data System (BI-RADS) category 1 or 2 (negative or benign findings) versus BI-RADS 3 (probably benign finding; short-term follow-up is recommended) recommendations by time after the vaccination.


Articles from Radiology are provided here courtesy of Radiological Society of North America

RESOURCES